RT Journal Article
SR Electronic
T1 Anger in Health, Benign Breast Disease and Breast Cancer: A Prospective Case–Control Study
JF In Vivo
JO In Vivo
FD International Institute of Anticancer Research
SP 973
OP 977
VO 28
IS 5
A1 ANTONIO BRUNO
A1 GIANLUCA PANDOLFO
A1 GIUSEPPE SCIMECA
A1 VALENTINA LEONARDI
A1 CLEMENTE CEDRO
A1 SERGIO RACCHIUSA
A1 ROCCO ANTONIO ZOCCALI
A1 MARIA ROSARIA A. MUSCATELLO
YR 2014
UL http://iv.iiarjournals.org/content/28/5/973.abstract
AB Background: The State-Trait Anger Expression Inventory 2 (STAXI-2) is a psychometric instrument measuring anger experience and expression. Associations between the STAXI-2 and risk of breast cancer (BC) are rarely considered together in a prospective study. Patients and Methods: A total of 117 women with breast symptoms referred for breast examination were selected and assessed before any diagnostic procedures. Results: Twenty-four patients with BC, 44 with benign breast disease (BBD) and 49 healthy individuals (HHS) were included. Scores for parameters state anger/feel like expressing anger physically (SANGP) were significantly higher in the HHS group (HHS vs. BBD: p=0.027; HHS vs. BC: p=0.025). BC patients showed a trend to lower scores in almost all scales of STAXI-2, except for the scales trait anger/angry temperament (TANGT), anger expression-in (AX-I), and anger control-out (AC-O), that were higher than the two other groups' scores. Conclusion: The results of this study do not support a specific link between STAXI-2 and breast cancer risk.